AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 311 min read$SNPS

DE GEUS AART sold $11.1M of SNPS

DE GEUS AART (EXECUTIVE CHAIR) sold 25,000 shares of SYNOPSYS INC (SNPS) at $445.55 ($11.14M total) on 2026-08-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DE GEUS AART
Published Aug 31, 2026, 10:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 11:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SNPS
Neutral
medium confidence
Mentioned
$SNPS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

The disclosed sale provides fresh data for traders monitoring insider sentiment.

02

Market read

New insider sale information, modest size, limited immediate market impact.

03

What to watch

Potential tax planning or diversification motives behind the 10b5‑1 execution.

Relevance 6/10Novelty 6/10Timing: filing posted 2026‑08‑31 after market close

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan indicates pre‑arranged sales.

Company-level read

Ticker impact

$SNPSNeutralMedium confidence
Context

Executive Chair Aart de Geus sold 25,000 shares for $11.1M via a 10b5‑1 plan, reducing his stake to 120,421 shares.

Expected impact

Potential short‑term downward pressure, likely limited to a few basis points.

Evidence & confidence

The sale is a primary Form 4 filing, new information, but $11M is not material for a large‑cap like Synopsys.

Market effects

Sector

Minimal impact on EDA/software sector; insider activity is routine.

Regional

U.S. market only; no broader regional effect.

Global

Low; Synopsys is a global player but the transaction is company‑specific.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event, not a negative signal.

Key entities

  • Company
    Synopsys Inc.

    U.S. listed EDA software provider (ticker SNPS).

  • Executive
    Aart de Geus

    Executive Chair of Synopsys, insider selling shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SNPS insider trading history →

Related articles

OCT 27
$SNPSMed

Why Should You Think About Synopsys Differently Now?

Synopsys (SNPS) trades at 80.8x P/E, focusing on AI-driven chip design and Ansys. Its IP business, which underperformed due to export restrictions and customer challenges, returned to growth in Q3 2026. Ansys revenue was 1.5x Design IP's revenue in the same quarter. Management highlights a shift to a licensing-plus-royalties model, with a $1B+ deal with Amazon.

finance.yahoo.com2 min
OCT 26
$SNPSMed

S&P lifts Synopsys to ’BBB+’ as chip-design leader capitalizes on AI demand

S&P Global Ratings upgraded Synopsys Inc's credit rating to 'BBB+' from 'BBB', citing strong long-term growth prospects driven by AI demand. The company expects mid-teens revenue growth through 2029 and improved profitability, with 2029 EBITDA margin projected at 49%. Synopsys is also accelerating cost synergies from its Ansys acquisition and expanding commercial traction, including a $1B+ contract with Amazon.

investing.com2 min
OCT 22
$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.

echo.ie2 min
OCT 20
$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.

finimize.com2 min